Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.55 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.40 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30679664 | 0.99 | PTGDR2 (0.54) | PTGDR2PTGER1PLA2G1BATG4BSRC | |
| SCHEMBL29964746 | 0.94 | PTGDR2 (0.57) | PTGDR2PTGER1PLA2G1BATG4BPTGDR | |
| SCHEMBL17061451 | 0.94 | PTGDR2 (0.57) | PTGDR2PTGER1PLA2G1BATG4BPTGDR | |
| SCHEMBL4052501 | 0.87 | PTGDR2 (0.51) | PTGDR2PLA2G1BATG4BTDP1SLC6A4 | |
| SCHEMBL29964495 | 0.87 | PTGDR2 (0.51) | PTGDR2PLA2G1BATG4BERN1HPGD | |
| SCHEMBL27159746 | 0.87 | PTGDR2 (0.51) | PTGDR2PLA2G1BATG4BERN1HPGD | |
| SCHEMBL20912029 | 0.87 | SRC (0.45) | PTGDR2PTGER1SRCPTGDRHPGD | |
| Hydrochloric Acid SCHEMBL15537884 | 0.86 | PTGDR2 (0.50) | PTGDR2PLA2G1BATG4BTDP1SLC6A4 | |
| SCHEMBL12462495 | 0.82 | PARP10 (0.51) | SRCHPGD | |
| SCHEMBL5472935 | 0.82 | SLC6A4 (0.53) | PTGDR2PTGER1PTGDRHPGDSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070072906-A1 | Pyrrole compounds | GLAXO GROUP LIMITED (GB) | 2007-03-29 | — | — | US | disclosed |
| US-20070072906-A1 | Pyrrole compounds | GLAXO GROUP LIMITED (GB) | 2007-03-29 | — | — | US | disclosed |
| US-20070072906-A1 | Pyrrole compounds | GLAXO GROUP LIMITED (GB) | 2007-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072906-A1 | Pyrrole compounds | PRMT9, EPOR, ADCYAP1R1 | PTGDR2 133/4885PTGER1 224/4885PLA2G1B 1671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.